These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 458246

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Plasminogen, plasminogen activator, and platelets in the regulation of clot lysis. Reconstitution and patient studies.
    Carroll RC, Radcliffe RD, Taylor FB, Gerrard JM.
    J Lab Clin Med; 1982 Dec; 100(6):986-96. PubMed ID: 6890569
    [Abstract] [Full Text] [Related]

  • 3. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.
    Taylor FB, Müller-Eberhard HJ.
    J Clin Invest; 1970 Nov; 49(11):2068-85. PubMed ID: 4248913
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clot retraction facilitates clot lysis.
    Carroll RC, Gerrard JM, Gilliam JM.
    Blood; 1981 Jan; 57(1):44-8. PubMed ID: 7448414
    [Abstract] [Full Text] [Related]

  • 7. A reconstituted dilute blood clot lysis assay for the medium throughput screening of thrombolytic compounds.
    Gadbut AP, Schullek JR, Hanel AM, MacAllan DR.
    Anal Biochem; 1999 May 15; 270(1):24-32. PubMed ID: 10328761
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
    Lam SC, Dieter JP, Strebel LC, Taylor TM, Muscolino G, Feinberg H, Le Breton GC.
    J Pharmacol Exp Ther; 1991 Dec 15; 259(3):1371-8. PubMed ID: 1762085
    [Abstract] [Full Text] [Related]

  • 12. Biochemical and biophysical conditions for blood clot lysis.
    Sabovic M, Blinc A.
    Pflugers Arch; 2000 Dec 15; 440(5 Suppl):R134-6. PubMed ID: 11005642
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Increased retraction of fibrin clots by endothelial cells of infants of diabetic mothers.
    Nappi C, Cerbone AM, Papa R, Di Minno G, Cortese A, Farace MS, Turco S, Montemagno U, Mancini M.
    Biol Res Pregnancy Perinatol; 1985 Dec 15; 6(3):141-2. PubMed ID: 3834950
    [Abstract] [Full Text] [Related]

  • 16. Cross-linking of alpha 2-antiplasmin to fibrin is a key factor in regulating blood clot lysis: species differences.
    van Giezen JJ, Minkema J, Bouma BN, Jansen JW.
    Blood Coagul Fibrinolysis; 1993 Dec 15; 4(6):869-75. PubMed ID: 7511944
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lysis of clots prepared from whole blood and plasma.
    Taylor FB, Carroll RC, Gerrard J, Esmon CT, Radcliffe RD.
    Fed Proc; 1981 May 15; 40(7):2092-8. PubMed ID: 7194803
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of concomitant thrombin-mediated fibrin formation enhances clot lysis in whole blood.
    Haskel EJ, Eisenberg PR, Abendschein DR.
    Blood Coagul Fibrinolysis; 1993 Feb 15; 4(1):7-13. PubMed ID: 8457655
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.